These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 19508347)
1. Clinical heterogeneity in progressive supranuclear palsy: problems of clinical diagnostic criteria of NINDS-SPSP in a retrospective study of seven Japanese autopsy cases. Sakamoto R; Tsuchiya K; Mimura M Neuropathology; 2010 Feb; 30(1):24-35. PubMed ID: 19508347 [TBL] [Abstract][Full Text] [Related]
2. Accuracy of clinical diagnosis of progressive supranuclear palsy. Osaki Y; Ben-Shlomo Y; Lees AJ; Daniel SE; Colosimo C; Wenning G; Quinn N Mov Disord; 2004 Feb; 19(2):181-9. PubMed ID: 14978673 [TBL] [Abstract][Full Text] [Related]
4. Accuracy of the National Institute for Neurological Disorders and Stroke/Society for Progressive Supranuclear Palsy and neuroprotection and natural history in Parkinson plus syndromes criteria for the diagnosis of progressive supranuclear palsy. Respondek G; Roeber S; Kretzschmar H; Troakes C; Al-Sarraj S; Gelpi E; Gaig C; Chiu WZ; van Swieten JC; Oertel WH; Höglinger GU Mov Disord; 2013 Apr; 28(4):504-9. PubMed ID: 23436751 [TBL] [Abstract][Full Text] [Related]
5. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia. Kanazawa M; Tada M; Onodera O; Takahashi H; Nishizawa M; Shimohata T Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652 [TBL] [Abstract][Full Text] [Related]
6. Natural history and clinical features of progressive supranuclear palsy: a clinical study. Diroma C; Dell'Aquila C; Fraddosio A; Lamberti S; Mastronardi R; Russo I; De Mari M; Iliceto G Neurol Sci; 2003 Oct; 24(3):176-7. PubMed ID: 14598074 [TBL] [Abstract][Full Text] [Related]
8. Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases. Birdi S; Rajput AH; Fenton M; Donat JR; Rozdilsky B; Robinson C; Macaulay R; George D Mov Disord; 2002 Nov; 17(6):1255-64. PubMed ID: 12465065 [TBL] [Abstract][Full Text] [Related]
9. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes? Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592 [TBL] [Abstract][Full Text] [Related]
10. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Jellinger KA Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Josephs KA; Dickson DW Mov Disord; 2003 Sep; 18(9):1018-26. PubMed ID: 14502669 [TBL] [Abstract][Full Text] [Related]
12. Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. Ahmed Z; Josephs KA; Gonzalez J; DelleDonne A; Dickson DW Brain; 2008 Feb; 131(Pt 2):460-72. PubMed ID: 18158316 [TBL] [Abstract][Full Text] [Related]
13. Progressive supranuclear palsy combined with Alzheimer's disease: a clinicopathological study of two autopsy cases. Sakamoto R; Tsuchiya K; Yoshida R; Itoh Y; Furuta N; Kosuga A; Sugai Y; Mimura M Neuropathology; 2009 Jun; 29(3):219-29. PubMed ID: 18992014 [TBL] [Abstract][Full Text] [Related]
14. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445 [TBL] [Abstract][Full Text] [Related]
15. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis]. Morimatsu M; Negoro K; Mori H Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349 [TBL] [Abstract][Full Text] [Related]